Scientists test nasal spray to calm brain inflammation in rare neurological disease
NCT ID NCT06868628
Summary
This early-stage study is testing whether a nasal spray called foralumab can reduce harmful brain inflammation and slow disease progression in people with multiple system atrophy (MSA), a rare and serious neurological disorder. The trial will enroll 5 patients to check the treatment's safety and see if it can improve symptoms and brain scans over 6 months. Researchers hope this approach could offer a new way to manage this currently incurable condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SYSTEM ATROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.